European Organisation For Research And Treatment Of Cancer - Eortc

This early-phase study tested the drug TG02 in 71 patients with aggressive brain tumors (anaplastic astrocytoma or glioblastoma). The goal was to find the safest dose when combined with either radiation or chemotherapy. The study focused on newly diagnosed elderly patients and th…

This study looked at how 830 women with early or locally advanced breast cancer were doing after finishing their main treatment. Researchers used questionnaires to measure quality of life, including physical and emotional health. The goal was to understand survivors' well-being, …